Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)

About this update from Zealand Pharma A/s

Company announcement No. 40 / 2026Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the “Program”) for week 33 (August 10 - August 14, 2026). The Program is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 (the Market Abuse Regulation, “MAR”) and Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”). Reference is made to company announcement no. 15 / 2026 dated May 7, 2026, which sets out the full terms of the Program. Under the Program, Zealand Pharma may repurchase shares for a total consideration of up to DKK 1.3 billion. The maximum number of shares that may be acquired under the Program is 7,152,557, and the Program commenced on May 7, 2026, and will be completed no later than October 31, 2026. The Company has appointed Danske Bank as lead manager for the Program. Danske Bank will make its own trading decisions independently of, and without influence from, the Company.Transactions executed in week 33The following transactions have been executed on Nasdaq Copenhagen (XCSE) under the Program during week 33 (August 10, 2026 - August 14, 2026):DateNumber of sharesAverage purchase price (DKK)Transaction value (DKK)Accumulated as per latest announcement2,470,000 741,654,00010/08/2026 24,000 326.91 7,845,84011/08/2026 25,000 333.82 8,345,50012/08/2026 25,000 328.60 8,215,00013/08/2026 25,000 337.10 8,427,50014/08/2026 25,000 336.18 8,404,500Accumulated (W33)124,000 41,238,340Total accumulatedunder the Program2,594,000 782,892,340Treasury shares and share capitalFollowing the transactions described above, Zealand Pharma holds a total of 3,464,842 treasury shares, corresponding to approximately 4.84% of the Company’s share capital. The total number of shares in Zealand Pharma is 71,578,758, each with a nominal value of DKK 1.Additional informationDetailed information on each transaction executed under the Program is available in the appendix to this company announcement.About Zealand PharmaZealand Pharma A/S (Nasdaq: ZEAL) is a bio...

View stock analysis, news, and events for Zealand Pharma A/s